NCT03935373

Brief Summary

To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2019

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 22, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 2, 2019

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

May 6, 2019

Status Verified

May 1, 2019

Enrollment Period

1 month

First QC Date

April 22, 2019

Last Update Submit

May 2, 2019

Conditions

Keywords

Immune regulationSjögren's syndromeGene modulationTraditional Chinese Medicine patternTraditional Chinese Medicine tongue diagnosisTraditional Chinese Medicine pulse diagnosisProteomicsOral microbiome

Outcome Measures

Primary Outcomes (7)

  • Immunity-related gene expression

    To evaluate the immunity-related gene expression for the Sjögren's syndrome and healthy control. DNA exome combine the GATK (Genome Analysis Toolkit) is a tool for detecting the ratio of immunity-related gene expression.

    One year

  • TCM pattern

    To evaluate the difference of TCM pattern between Sjögren's syndrome and healthy control. TCM pattern is a tool for detecting the constitution.

    One year

  • TCM tongue diagnosis

    To evaluate the difference of TCM tongue diagnosis between Sjögren's syndrome and healthy control. TCM tongue diagnosis is a tool for detecting tongue expression.

    One year

  • TCM pulse diagnosis

    To evaluate the difference of TCM pulse diagnosis between Sjögren's syndrome and healthy control. TCM pulse diagnosis is a tool for detecting pulse of radial artery.

    One year

  • Heart rate variability (HRV)

    To evaluate the difference of Heart rate variability (HRV) between Sjögren's syndrome and healthy control. HRV is a tool for detecting the ratio between High-frequency (HF) activity and low-frequency (LF) activity.

    One year

  • Immunity-related proteomics expression

    To evaluate the proteomics for the Sjögren's syndrome and healthy control. Proteomics is a tool for detecting the ratio of immunity-related proteomics expression.

    One year

  • Immunity-related microbiome expression

    To evaluate the oral microbiome for the Sjögren's syndrome and healthy control. Oral microbiome is a tool for detecting the ratio of immunity-related microbiome expression.

    One year

Study Arms (2)

Sjögren's syndrome

Sjögren's syndrome patients were screened in the rheumatology outpatient departments and Center for Traditional Medicine at Taipei Veterans General Hospital, and were enrolled with the inclusion criteria: (1) primary or secondary SS; (2) aged between 20 and 75 years; (3) fulfilled the 2002 American-European Consensus Criteria for SS (AECG); (4) had no abnormal findings of immune, liver, kidney, or blood function evaluations. And the exclusion criteria were: (1) a history of alcohol abuse, diabetes mellitus, or major life-threatening condition; (2) pregnancy or breastfeeding; or (3) steroid pulse therapy within three months prior to the commencement of our study.

Diagnostic Test: DNA Exome sequencingDiagnostic Test: Oral microbiomeDiagnostic Test: ProteomicsDiagnostic Test: RNA sequencingDiagnostic Test: CytokineDiagnostic Test: Traditional Chinese Medicine patternDiagnostic Test: Traditional Chinese Medicine tongue diagnosisDiagnostic Test: Traditional Chinese Medicine pulse diagnosisDiagnostic Test: Heart rate variabilityDiagnostic Test: Schirmer's testDiagnostic Test: Blood function test, liver function test, kidney function test, and immune function test

Health subjects

Health subjects were screened in the rheumatology outpatient departments and Center for Traditional Medicine at Taipei Veterans General Hospital, and were enrolled with the inclusion criteria: (1) aged between 41 and 63 years (which the age could match the SS patients enrolling in the SS-1 trial); (2) had no chronic inflammatory illness. And the exclusion criteria were: (1) a history of alcohol abuse, diabetes mellitus, or major life-threatening condition; (2) pregnancy or breastfeeding; (3) abnormal findings of immune, liver, kidney, or blood function evaluations; (4) total sleeping time insufficiency less than 6 hours before one day of enrollment; (5) ever took the conventional medicine or hormone within one month; (6) ever encountered the acute illness, allergy reaction, immune, or rheumatic disease within one month.

Diagnostic Test: DNA Exome sequencingDiagnostic Test: Oral microbiomeDiagnostic Test: ProteomicsDiagnostic Test: RNA sequencingDiagnostic Test: CytokineDiagnostic Test: Traditional Chinese Medicine patternDiagnostic Test: Traditional Chinese Medicine tongue diagnosisDiagnostic Test: Traditional Chinese Medicine pulse diagnosisDiagnostic Test: Heart rate variabilityDiagnostic Test: Blood function test, liver function test, kidney function test, and immune function test

Interventions

DNA Exome sequencingDIAGNOSTIC_TEST

The DNA of Sjögren's syndrome patients and health subjects will take to do the DNA Exome sequencing.

Health subjectsSjögren's syndrome
Oral microbiomeDIAGNOSTIC_TEST

The saliva of Sjögren's syndrome patients and health subjects will take to do the oral microbiome.

Health subjectsSjögren's syndrome
ProteomicsDIAGNOSTIC_TEST

The protein of Sjögren's syndrome patients and health subjects will take to do the proteomics.

Health subjectsSjögren's syndrome
RNA sequencingDIAGNOSTIC_TEST

The RNA of Sjögren's syndrome patients and health subjects will store to do the RNA sequencing.

Health subjectsSjögren's syndrome
CytokineDIAGNOSTIC_TEST

The serum of Sjögren's syndrome patients and health subjects will store to do the cytokine detection in the future.

Health subjectsSjögren's syndrome

Sjögren's syndrome patients and health subjects will take the Traditional Chinese Medicine pattern.

Health subjectsSjögren's syndrome

Sjögren's syndrome patients and health subjects will take the Traditional Chinese Medicine tongue diagnosis.

Health subjectsSjögren's syndrome

Sjögren's syndrome patients and health subjects will take the Traditional Chinese Medicine pulse diagnosis.

Health subjectsSjögren's syndrome
Heart rate variabilityDIAGNOSTIC_TEST

Sjögren's syndrome patients and health subjects will take the heart rate variability.

Health subjectsSjögren's syndrome
Schirmer's testDIAGNOSTIC_TEST

Sjögren's syndrome patients will take the Schirmer's test.

Sjögren's syndrome

Sjögren's syndrome patients and health subjects will take the blood function test (WBC, RBC, Hb, HCT, Platelet, MCV, MCH, and MCHC), liver function test (AST and ALT), kidney function test (BUN and Cre), and immune function test (RF, Anti-SSA, Anti-SSB Ab, ESR, and CRP)

Health subjectsSjögren's syndrome

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Sjögren's syndrome patients and Health subjects were screened in the rheumatology outpatient departments and Center for Traditional Medicine at Taipei Veterans General Hospital.

You may qualify if:

  • (1) primary or secondary SS
  • (2) aged between 20 and 75 years
  • (3) fulfilled the 2002 American-European Consensus Criteria for SS (AECG)
  • (4) had no abnormal findings of immune, liver, kidney, or blood function evaluations.

You may not qualify if:

  • (1)a history of alcohol abuse, diabetes mellitus, or major life-threatening condition
  • (2) pregnancy or breastfeeding
  • (3) steroid pulse therapy within three months prior to the commencement of our study.
  • Health Subjects
  • (1) aged 20 and 75 years
  • (2) had no chronic inflammatory illness.
  • (1) a history of alcohol abuse, diabetes mellitus, or major life-threatening condition
  • (2) pregnancy or breastfeeding
  • (3) abnormal findings of immune, liver, kidney, or blood function evaluations
  • (4) total sleeping time insufficiency less than 6 hours before one day of enrollment
  • (5) ever took the conventional medicine or hormone within one month
  • (6) ever encountered the acute illness, allergy reaction, immune, or rheumatic disease within one month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ching-Mao Chang

Taipei, Taiwan (r.o.c.), 112, Taiwan

Location

Biospecimen

Retention: SAMPLES WITH DNA

1. The DNA of Sjögren's syndrome patients and health subjects will take to do the DNA Exome sequencing. 2. The saliva of Sjögren's syndrome patients and health subjects will take to do the oral microbiome. 3. The protein of Sjögren's syndrome patients and health subjects will take to do the proteomics. 4. The RNA of Sjögren's syndrome patients and health subjects will store to do the RNA sequencing. 5. The plasma of Sjögren's syndrome patients and health subjects will store to do the cytokine detection in the future.

MeSH Terms

Conditions

Sjogren's Syndrome

Interventions

MicrobiotaBase SequenceTh1-Th2 BalanceLiver Function TestsKidney Function Tests

Condition Hierarchy (Ancestors)

Arthritis, RheumatoidArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesXerostomiaSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Microbiological PhenomenaBiotaBiodiversityEcosystemEnvironmentEcological and Environmental PhenomenaBiological PhenomenaEnvironment and Public HealthMolecular StructureBiochemical PhenomenaChemical PhenomenaGenetic StructuresGenetic PhenomenaImmune System PhenomenaDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Urological

Study Officials

  • Ching-Mao Chang, M.D., Ph.D.

    Taipei Veterans General Hospital, Taiwan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2019

First Posted

May 2, 2019

Study Start

April 1, 2019

Primary Completion

May 15, 2019

Study Completion

December 31, 2019

Last Updated

May 6, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations